Healthcare Services Industry Overview

The nuclear medicine market consists of sales of nuclear medicine and related products by entities (organizations, sole traders, and partnerships) that are used to assess the health of organs or tissue or to identify and remove any diseased or damaged organs or tissue. Nuclear medicine refers to a specialised area of radiology that uses radioactive material inside the body to inspect the overall health condition of the concerned patient. This branch of radiology is frequently used to identify and treat abnormalities that first appear very early in the course of a disease, such as thyroid cancer. The main types of nuclear medicine are diagnostic and therapeutic. A diagnostic is an examination to identify a person's distinct areas of strength and weakness to identify a condition, disease, or illness. The applications involved cardiology, lymphoma, thyroid, neurology, oncology, and other applications. The end-users included hospitals and clinics, diagnostic centers, and other end-users. The nuclear medicine market research report is one of a series of new reports from The Business Research Company that provides nuclear medicine market statistics, including nuclear medicine industry global market size, regional shares, competitors with a nuclear medicine market share, detailed nuclear medicine market segments, market trends and opportunities, and any further data you may need to thrive in the nuclear medicine industry. This nuclear medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global nuclear medicine market size is expected to grow from $6.00 billion in 2021 to $6.77 billion in 2022 at a compound annual growth rate (CAGR) of 12.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The nuclear medicine market is expected to grow to $11.20 billion in 2026 at a CAGR of 13.4%. The increasing constancy and prevalence of cardiovascular disease (CVD) and cancer are expected to propel the growth of the nuclear medicine market going forward. Cardiovascular diseases (CVDs) are a group of heart and blood vessel disorders, and cancer is a disease in which cells grow out of control and spread to other body parts. Nuclear cardiac imaging can help diagnose cardiac diseases more quickly. Nuclear medicine therapy is a method to treat cancer that might be used with or after other therapy options, such as surgery and chemotherapy. As a result, the growing constancy and prevalence of cardiovascular disease and cancer increase the demand for the nuclear medicine market. For instance, in 2020, according to GLOBOCAN, a US-based cancer observatory, there were 19.29k new cancer cases in the world in the year 2020, and 28.88k cases are anticipated by 2040. Further, in 2019, according to the World Health Organization (WHO), a Switzerland-based international organisation responsible for public health, estimates that 17.9 million people worldwide died from cardiovascular diseases (CVDs) in the year 2019, accounting for 32% of all fatalities. 85% of these fatalities were caused by heart attack and stroke. Therefore, the growing constancy and prevalence of cardiovascular diseases and cancer are driving the nuclear medicine market.  Product innovation is the key trend gaining popularity in the nuclear medicine market. Major companies operating in the nuclear medicine market are focused on developing new innovative products to strengthen their position. For instance, in March 2021, GE Healthcare, a US-based company that deals with nuclear medicine, launched Star Guide, a new nuclear medicine system to assist in advancing precision health and theragnostics. StarGuide uses the most recent developments in Cadmium Zinc Telluride (CZT) technology to assist providers in exploring and better understanding the patient's condition, enhancing patient outcomes throughout the continuum of care. It has unique features such as digital focus detectors and 360-degree imaging of the system that are intended to support improved theragnostic capabilities in nuclear medicine and advanced precision health. In August 2019, Bracco Imaging, an Italy-based healthcare company, acquired Blue Earth Diagnostics for an undisclosed amount. This acquisition will enable both companies to realise their full potential by significantly broadening the combined portfolio in precision medicine and personalised diagnostics while expanding the wide range of nuclear oncology imaging solutions in the Urology segment and other specialties. Blue Earth Diagnostics is a UK-based company operating in nuclear medicine. Major players in the nuclear medicine market are Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd, Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organization, Cardinal Health Inc., GE Healthcare, Curium Pharma7, Advanced Accelerator Applications, Nordion Inc., The Institute for Radioelements, Eczacbas-Monrol, Siemens Healthineers AG, and Cambridge Isotope Laboratories Inc. North America was the largest region in the nuclear medicine market in 2021. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this nuclear medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the nuclear medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The global nuclear medicine market is segmented - 1) By Type: Diagnostic, Therapeutic 2) By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Application 3) By End-User: Hospitals and Clinics, Diagnostic Centers, Other End Users

The pyrogen testing market consists of sales of pyrogen testing and related services by entities (organizations, sole traders and partnerships) that provide pyrogen testing to check the presence or absence of pyrogens in all aqueous parenterals. Pyrogen testing determines the presence of bacterial toxins in vaccines, biotechnological products, and drugs, which induces fever in humans. It also determines the presence of microbes and their metabolites in drugs during the manufacturing process. The main types of tests in pyrogen testing are LAL test, in vitro test, and rabbit test. The LAL (Limulus Amebocyte Lysate) test is a test for the determination of bacterial endotoxins, which uses an Amebocyte Lysate of the Limulus crab. The different products and services include assays, kits, reagents, instruments, services and used in pharmaceutical and biologics, medical devices, others. The global pyrogen testing market is expected to grow from $1.21 billion in 2021 to $1.25 billion in 2022 at a compound annual growth rate (CAGR) of 3.4%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $2.00 billion in 2026 at a CAGR of 12.5%. The rising investments in research and development in the pharmaceutical and biotechnology industries contributed to the growth of the pyrogen testing market. Pyrogen testing is used by pharmaceutical, biotech, and various drug manufacturing companies for the safe manufacturing and introduction of infection-free products into the market. For instance, in 2019, major players in pharmaceuticals market Roche, AstraZeneca and Merck has invested heavily in R&D activities. Roche invested around $12 billion which represented 19% of its $63.3 billion in sales. Therefore, high investments in research and development by the pharmaceuticals companies drive the pyrogen testing market. Companies are focusing on the evolution of various animal-free pyrogen testing methods such as monocyte activation assay (MAT) to overcome constraints of rabbit pyrogen testing method and LAL test, and to produce a human treatment of animals. MAT provides a high level of prediction of pyrogenic activity and also stimulates fever reaction better than the RPT or BET/LAL. MAT pyrogen testing method is used to detect both endotoxin and non-endotoxin pyrogens, but the LAL test is limited to detect only endotoxin pyrogen. For instance, Merck focused on two MAT systems for the detection of pyrogens namely PyroDetect, PyroMAT. Major players in the pyrogen testing market are Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories Inc., Lonza Group, Ellab A/S, Nelson Laboratories Inc., Associates of Cape Cod Inc., GenScript, BioMerieux, Hyglos GmbH, Sanquin, Wako Chemicals Usa Inc and Pyrostar. North America was the largest region in the pyrogen testing market in 2021. Asia Pacific is expected to continue to be the fastest growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the pyrogen testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The global pyrogen testing market is segmented - 1) By Test Type: LAL Test, In Vitro Test, Rabbit Test 2) By Product and Service: Assays, Kits, and Reagents, Instruments, Services 3) By Application: Pharmaceutical and Biologics, Medical Devices, Others

The trauma care center market consists of the sale of trauma care center services by entities (organizations, sole traders, and partnerships) that are used for taking care of patients suffering from traumatic injuries. Trauma care centers refer to a center in the hospital that is equipped with specialized staff who can take care of trauma cases. The main objective of the trauma system is to provide the right service to the right patients. Trauma care centers are usually expensive, but they have trained staff that can handle a variety of conditions and medical cases. The main types of facilities provided by trauma care centers are in-house and standalone. The in-house trauma care center services refer to a trauma care facility that is a specialized area within a hospital building. It is used to give special care to trauma patients. The different trauma injuries include falls, traffic-related injuries, stabs or wounds or cuts, burn injuries, brain injuries, and others. The various services provided by trauma care centers are inpatient, outpatient, and rehabilitation. The trauma care centers market research report is one of a series of new reports from The Business Research Company that provides trauma care center market statistics, including Trauma care centers industry global market size, regional shares, competitors with a trauma care center market share, detailed trauma care center market segments, market trends and opportunities, and any further data you may need to thrive in the trauma care centers industry. This trauma care centers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global trauma care centers market size is expected to grow from $ 18.49 billion in 2021 to $ 19.98 billion in 2022 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The trauma care center market is expected to grow to $ 24.73 billion in 2026 at a CAGR of 5.5%. The growing number of traumatic injury-related emergency department visits is expected to propel the growth of the trauma care center market going forward. A traumatic injury refers to physical injuries that are sudden and severe in nature and which require immediate medical attention. The growing number of traumatic injury-related emergency department visits compels the trauma care center market to provide better quality services for patients, which leads to an increase in the demand for trauma care centers. For instance, according to a report published by the Centers for Disease Control and Prevention, an American government agency, in 2022, there will be approximately 130 million visits to emergency departments in America, of which 35 million visits are related to various injuries. Furthermore, according to a journal article published by the National Library of Medicine, an American medical library in 2021, there was an increase in penetration trauma from 10.3% to 13.0% in 2021. Therefore, the growing number of traumatic injury-related emergency department visits is driving the growth of the trauma care center market. Technological advancements are key trends gaining popularity in the trauma care center market. Many companies or hospitals operating in the trauma care center market are focused on developing technologically advanced products to strengthen their market position and provide the best treatment for trauma patients. For instance, in November 2020, Johnson and Johnson Medtech, a US-based healthcare services and, technology company, introduced its new surgical robotic platform called Ottava. The new system is designed in such a way that it has six arms to provide more control and flexibility during surgery. In addition that this platform has a zero footprint design to enable patient access, increase space in the operating room, and improve the workflow. This system would help in the treatment of trauma patients more efficiently and effectively. According to the company, there are no robotic platforms available in the market which provides control and coordination across a full breadth of the procedure. In February 2022, Criticare Asia Hospitals, an Indian multi-specialty hospital acquired Kohinoor hospital for an undisclosed amount. This acquisition would help Criticare become one of the most advanced multispecialty hospitals where Criticare would have three facilities in total which has 24 hours trauma care and other facilities along with a large number of medical staff to address all major and minor health issues. Kohinoor Hospital is an Indian multi-specialty hospital that provides a trauma care center and various medical treatments. Major players in the trauma care centers market are University of Alabama Hospital, Banner University Medical Center Phoenix, St. Joseph's Hospital and Medical Center, Albany Medical Center, Ascension St. John Hospital, Baylor University Medical Center, Bellevue Hospital Center, Murnau Trauma Center, China Medical University Hospital, Gohealth Urgent Care, CityMD Urgent Care, Fastmed Urgent Care, Carenow Urgent Care, American Family Care, and Columbia Asia Hospitals. North America was the largest region in the trauma care centers market in 2021. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the trauma care centers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the trauma care centers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The global trauma care centers market is segmented - 1) By Facility: In-house, Standalone 2) By Trauma: Falls, Traffic-Related Injuries, Stab or Wound or Cut, Burn Injury, Brain Injury, Other Injuries 3) By Service: Inpatient, Outpatient, Rehabilitation

The hospice care market consists of sales of hospice care services by entities (organizations, sole traders, and partnerships) that are primarily used for providing care services at a point of a disease that cannot be cured or controlled by treatment. Hospice care is a special kind of care that focuses on improving the quality of life for people who are experiencing an advanced, life-limiting illness or their caregivers. The main goal of hospice care services is to comfort the patients while allowing them to enjoy their last stage of life. The main types of hospice care are nursing, medical supply, physician services, and other services. Nursing services refer to assigning case manager nurses to a hospice patient. Nursing services are used for nursing care, in which nurses visit patients one to three days a week. Caregivers can also access an on-call nurse 24 hours daily, depending on the need. Home settings, hospitals, specialty nursing homes, and hospice care centers are the applications of hospice care. The hospice care market research report is one of a series of new reports from The Business Research Company that provides hospice care market statistics, including hospice care industry global market size, regional shares, competitors with a hospice care market share, detailed hospice care market segments, market trends and opportunities, and any further data you may need to thrive in the hospice care industry. This hospice care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global hospice care market is expected to grow from $3.35 billion in 2021 to $3.65 billion in 2022 at a compound annual growth rate (CAGR) of 8.87%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The hospice care market is expected to reach $5.47 billion in 2026 at a compound annual growth rate (CAGR) of 10.63%. The rise in the prevalence of chronic diseases is expected to propel the growth of the hospice care market. Chronic diseases refer to conditions lasting a year or more, requiring ongoing medical care, or limiting daily life activities. Chronic diseases are increasing due to the increasing use of tobacco products, poor nutrition, physical inactivity, excessive use of alcohol, and others. Hospice care is opted by several patients suffering from severe chronic diseases, including cancer. For Instance, according to a research report published by American Action Forum in September 2020, chronic disease prevalence and costs are rising in the United States. They are expected to keep increasing as the disease prevalence among children and young adults rises. Chronic disease is a serious healthcare problem since the rising cost of chronic disease in the United States totals annually $3.7 trillion, which is around 19.6% of the country's gross domestic product (GDP). Therefore, a rise in the prevalence of chronic diseases is expected to drive the growth of the hospice care market. New technology penetration is the key trend in the hospice care market. Major companies operating in the market are introducing new technological innovations such as using new machine learning tools to identify patients who need their services earlier in their illness and ensure that patients receive the appropriate level of home care as their illness progresses. For instance, in February 2022, Amedisys Inc., a US-based hospice provider, adopted Medalogix’s Muse, which enables better end-of-life care for patients by using machine learning to predict patient transitions. Amedisys In focuses on the last seven days of patient transition through this enterprise deployment. In addition to identifying more patients who require greater levels of care, Muse also better prepares the care team to take action. In December 2021, Traditions Health, a US-based hospice and home health services provider, acquired Homestead Hospice and Palliative Care for an undisclosed amount. With this acquisition, Traditions Health will develop and spread its end-of-life care across the country while maintaining the ongoing and regular provision of the highest caliber of care for our patients. Homestead Hospice and Palliative Care is a Georgia-based service provider of hospice care and palliative care. Major players in the hospice care market are Covenant Care, National Association for Home Care and Hospice, Kindred at Home, PruittHealth, Dierksen Hospice, National Hospice and Palliative Care Organization, Oklahoma Palliative and Hospice Care, Benton Hospice Services, Alzheimer's Association, New Hampshire Hospice and Palliative Care Organization, VITAS Healthcare, LHC Group Inc, Amedisys, Gentiva Health Services, Samaritan Health Services, Brookdale Senior Living Inc and Seasons Hospice. North America was the largest region in the hospice care market in 2021. The regions covered in the hospice care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the hospice care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The global hospice care market is segmented - 1) By Type: Nursing Services, Medical Supply Services, Physician Services, Other Type Of Services 2) By Application: Home Settings, Hospitals, Specialty Nursing Homes, Hospice Care Centres

The oral care market consists of sales of oral care products by entities (organizations, sole traders, and partnerships) that are used to prevent tooth decay, maintain oral hygiene and maintain freshness while breathing. Oral care is crucial for maintaining good oral health, lowering the risk of infection and inflammation in the oral cavity, and preventing systemic infection from the oral cavity. It includes mechanical cleaning (tooth brushing, flossing), mouth washing (bland rinses), and hydration and lubrication (applying moisturizing agents). The main product types of oral care are toothpaste, mouth wash and rinse, teeth whitening, dental floss, toothbrush, and orthodontic wax. Toothpaste is used to clean, maintain, and improve the appearance and health of teeth. Toothpaste is a paste or gel dentifrice used to remove food particles and dental plaque from the teeth, control halitosis, and supply active chemicals that fight tooth decay and gum disease. The oral care products are distributed through stores and non-store based. These products are used by hospitals and dental clinics. The oral care market research report is one of a series of new reports from The Business Research Company that provides oral care market statistics, including oral care industry global market size, regional shares, competitors with an oral care market share, detailed oral care market segments, market trends and opportunities, and any further data you may need to thrive in the oral care industry. This oral care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global oral care market is expected to grow from $38.70 billion in 2021 to $41.15 billion in 2022 at a compound annual growth rate (CAGR) of 6.32%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The oral care market is expected to reach $53.85 billion in 2026 at a compound annual growth rate (CAGR) of 6.96%. Increased awareness of dental health care is significantly contributing to the growth of the oral care market. Dental or oral health includes teeth, gums, and mouth and aims to keep the mouth healthy and avoid gum disease and tooth decay. Various factors, including sugar consumption, cigarette use, alcohol use, and poor oral hygiene, are the root causes of oral diseases. Oral care helps to maintain hygiene and keep the mouth disease free. According to the 2022 State of America's Oral Health and Wellness Report, a US-based association that provides crucial education and research and supports key policies to prevent dental disease, 92% of adults and 96% of parents say maintaining good dental health is very important for overall health. One in five (20%) persons think that a problem with their oral health directly impacted their general health. Therefore, awareness of dental health care drives the oral care market growth. Technological advancement is a key trend in the oral care market. Major players in the oral care market are adopting CAD/CAM technology for providing oral care services. CAD stands for "computer-assisted design" that uses computer-based software to assist in design processes and producing two-dimensional (2-D) drawings and three-dimensional (3-D) models. Computer-Assisted Manufacture (CAM) helps to automate a production process via software and computer-controlled equipment. In oral care with CAD/CAM technology, the tooth is prepared for the crown by drilling it and then a computer image is taken. The crown is made in-office using a machine that receives this image. For instance, in February 2022, Planmeca, US-based dental imaging and CAD/CAM equipment manufacturer, introduced the Planmeca PlanMill 35. The new Planmeca PlanMill 35 is one of three components of the Planmeca FIT CAD/CAM system. In January 2020, Colgate, a US-based consumer products company specializing in the production, distribution, and provision of household, oral care, health care, personal care, and veterinary products, acquired Hello. Through this acquisition, Colgate will expand its oral care sector and thrive to provide its customers with the best oral care services. Hello is a US-based oral care brand specializing in adult and kid’s toothpaste, mouth rinse, toothbrushes, and floss. Major players in the oral care market are Procter & Gamble Co, Johnson & Johnson Services Inc, GlaxoSmithKline, Church & Dwight Co Inc, Colgate Palmolive Co, Unilever , Sunstar Suisse, Lion Corporation, Dr Fresh, Dentaid Research Center, Koninklijke Philips NV, Oral-B Laboratories Ltd, Henkel AG & Co KG Aa, Amway, Dabur and Jordan AS. Asia Pacific was the largest region in the oral care market in 2021. The regions covered in the oral care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the oral care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The global oral care market is segmented - 1) By Product Type: Toothpaste, Mouth Wash and Rinse, Teeth Whitening, Dental Floss, Tooth Brush, Orthodontic Wax 2) By Distribution Channel: Store-based, Non-Store-Based 3) By End User: Hospitals, Dental Clinics

The healthcare analytical testing service market consists of sales of healthcare analytical testing services by entities (organizations, sole traders, and partnerships) that are used to perform quality control of active pharmaceutical ingredients and intermediates in drug development, diagnosis of diseases, analytical method validation, active pharmaceutical ingredient analysis, and testing of biological samples in research and development. Healthcare analytical testing service refers to the process of validation of procedures used in drug discovery and development, finished products, and the detection of microorganisms in biological drugs, suspensions, and emulsions. The main types of healthcare analytical testing services are bioanalytical testing services, physical characterization services, method development and validation testing services, raw material testing services, batch-release testing services, stability testing, microbial testing services, and others. Bioanalytical testing services use medical devices to provide pharmacokinetics and pharmacodynamics aspects and determine drug and metabolite content in blood and urine used in pharmacological and toxicological research. Bioanalytical refers to the process of detection of metabolites in biological fluids. The different end users include pharmaceutical and biopharmaceutical companies, medical device companies, and clinical research organizations. The healthcare analytical testing service market research report is one of a series of new reports from The Business Research Company that provides healthcare analytical testing service market statistics, including healthcare analytical testing service industry global market size, regional shares, competitors with a healthcare analytical testing service market share, detailed healthcare analytical testing service market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare analytical testing service industry. This healthcare analytical testing service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry. The global healthcare analytical testing service market size is expected to grow from $4.11 billion in 2021 to $4.83 billion in 2022 at a compound annual growth rate (CAGR) of 17.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The healthcare analytical testing service market is expected to grow to $8.06 billion in 2026 at a CAGR of 13.6%. Increasing cases of chronic diseases are expected to drive the healthcare analytical testing service market going forward. Chronic diseases refer to diseases that persist in humans for more than three months, and these diseases include arthritis, asthma, cancer, diabetes, and so on. Healthcare analytical testing services are essential for the diagnosis and early treatment of millions of patients suffering from chronic diseases. For instance, according to Firstpost, an India-based online news and media website, diabetes cases in India are expected to double to 134 million by 2025. Therefore, increasing cases of chronic diseases are driving the growth of the healthcare analytical testing service market. Technological advancement is the key trend gaining popularity in the healthcare analytical testing service market. Major market players are creating innovative technologies to sustain their position in the market. For instance, in April 2022, Charles River Laboratories International Inc., a US-based pharmaceutical company that provides clinical analytical and drug discovery services, and Valo Health Inc., a US-based company operating in the drug discovery process, launched the Logica analytical platform. This integrated AI-powered drug testing platform helps to design drug molecules, synthesis capabilities, and DNA-encoded libraries and directly translates biological testing outputs into optimized preclinical results to enhance drug discovery and biological testing. In December 2021, Laboratory Corporation, a US-based life science company specializing in diagnostic and contract research services, acquired Toxikon Corporation for an undisclosed amount. This acquisition helps Laboratory Corporation to expand its product portfolio in non-clinical analytical drug development and medical device analytical testing services. Toxikon Corporation is a US-based contract research organization specializing in nonclinical testing, drug development testing, medical device testing, and toxicology analytical services. Major players in the healthcare analytical testing services market are Laboratory Corporation, Eurofins Scientific SE, Charles River Laboratories International Inc, Pace Analytical Services LLC, WuXi AppTec, PPD Inc, Intertek Group plc, Syneos Health, ICON plc, Merck KGaA, SourceBio International plc, Element Materials Technology Group, Thermo Fisher Scientific Inc, Danaher Corporation, Almac Group, Steris Corporation, Sartorius AG, ALS Limited, Anacura Life Sciences, and Impact Analytical Testing Lab. North America was the largest region in the healthcare analytical testing services market in 2021. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare analytical testing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the healthcare analytical testing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The global healthcare analytical testing services market is segmented - 1) By Type: Bioanalytical Testing Services, Physical Characterization Services, Method Development And Validation Testing Services, Raw Material Testing Services, Batch-Release Testing Services, Stability Testing, Microbial Testing Services, Other Types 2) By End User: Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Contract Research Organizations

The healthcare provider network management market consists of sales of healthcare provider network management services by entities (organizations, sole traders, and partnerships) that help to improve claim accuracy, documentation, data management, and automation. Healthcare provider network management provides a point for access to information about health insurance plans, government regulations and processes, pricing, and other data within the healthcare organization. It helps financial organizations to manage claims with more accuracy, manage provider networks with superior efficiency, and improve provider satisfaction. The main types of components in the healthcare provider network management market are network management services and network management software. The network management services market refers to services used to provide access to plans of patient care, pathology report results, and medical and pharmacy claims utilization data. The network management services refer to network maintenance, monitoring of devices, and monthly report status. The various deployment types include on-premises and cloud, and the end users are private payers and public payers. The healthcare provider network management market research report is one of a series of new reports from The Business Research Company that provides healthcare provider network management market statistics, including healthcare provider network management industry global market size, regional shares, competitors with a healthcare provider network management market share, detailed healthcare provider network management market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare provider network management industry. This healthcare provider network management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry. The global healthcare provider network management market size is expected to grow from $2.84 billion in 2021 to $3.35 billion in 2022 at a compound annual growth rate (CAGR) of 17.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The healthcare provider network management market is expected to reach $5.96 billion in 2026 at a CAGR of 15.5%. The rising patient population is expected to propel the growth of the healthcare provider network management market going forward. The patient population refers to individuals living with certain medical conditions and illnesses. With the increasing patient population, the patient flow to hospitals also increases. Healthcare provider network management helps providers monitor patient records to predict hospitalization and readmission and enables them to manage care-management programs. For instance, according to the American Hospital Association, a US-based organization that represents all types of hospitals and health care networks' 2020 Annual Survey, over 33.35 million hospital admissions were registered in the US during 2020. Therefore, the rising patient population is driving the growth of the healthcare provider network management market. Technological advancement is the key trend gaining popularity in the healthcare provider network management market. Major market players are concentrating their efforts on creating innovative technologies to sustain their position in the market. For instance, in March 2021, Innovaccer Inc., a US-based digital healthcare company, launched a provider network management solution that is powered by the Innovaccer health cloud and an integrated platform to assist healthcare payers to enhance provider network performance, data collection, and analysis. Payers can educate and reach out to providers as well as offer services such as point-of-care alerts to improve quality scores, the total cost of care, and member health value. In January 2022, Centene Corporation, a US-based managed care company, acquired Magellan Health Inc. for a deal amount of $2.2 billion. This acquisition will help Centene Corporation to increase its behavioral and specialty healthcare service portfolio and integrate healthcare solutions for patients at lower medical costs. Magellan Health Inc. is a US-based provider network management organization. Major players in the healthcare provider network management market are Optum Inc, Atos SE, Cognizant, Symphony AyasdiAI, Infosys Technologies Limited, Change Healthcare Inc, SkyGen, McKesson Corporation, Centene Corporation, OSPLabs, Virtusa Corporation, Appian Corporation, Salesforce Inc, Evolent Health Inc, and Coforge. North America was the largest region in the healthcare provider network management market in 2021. The regions covered in the healthcare provider network management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the healthcare provider network management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The global healthcare provider network management market is segmented - 1) By Component: Network management services, Network management software 2) By Deployment Type: On-Premises, Cloud 3) By End User: Private Payers, Public Payers

The healthcare technology management market consists of sales of healthcare technology management services by entities (organizations, sole traders, and partnerships) that are used to improve patient care and monitoring through remote locations. Healthcare technology management refers to the organized process of preparing and managing healthcare technology applications and software that help to provide optimum patient care in hospitals and clinics at a low cost. This technology helps to enhance surgical outcomes and maintain patent data security. The main types of services in the healthcare technology management market are maintenance and repair, capital planning, integrated software platform, labor management, supply chain (procurement), cyber security, quality & regulatory compliance. The maintenance and repair services in healthcare technology management are used to maintain the working operation of various equipment used in hospitals, repair them, and improve the capacity shelf life of machines. Maintenance and repair refers to improvements in the capacity of machines. The various types of facilities include acute care facilities, post-acute care facilities, and non-acute care facilities. The healthcare technology management market research report is one of a series of new reports from The Business Research Company that provides healthcare technology management market statistics, including healthcare technology management industry global market size, regional shares, competitors with a healthcare technology management market share, detailed healthcare technology management market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare technology management industry. This healthcare technology management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry. The global healthcare technology management market size is expected to grow from $13.70 billion in 2021 to $15.69 billion in 2022 at a compound annual growth rate (CAGR) of 14.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The healthcare technology management market is expected to reach $25.78 billion in 2026 at a CAGR of 13.2%. The rising need for data security is expected to propel the healthcare technology management market going forward. Data security is the process of protecting data from unauthorized access and data corruption. The need for data security is increasing due to the rising activities of hackers who steal patient data to commit fraud. Healthcare technology management helps to protect the data from hacking, with the help of production and operations management techniques, which helps to identify the fish mail and report it directly to the user. For instance, according to a report published by Forbes, a US-based business magazine, in January 2022, cyber-attacks increased to 71% in the healthcare sector in 2021. In addition, in July 2021, International Business Machines Corporation, a US-based technology company, the healthcare data breach cost increased to $9.4 million in 2021 which was $2 million in 2020, there is an increase of $4.24 million in 2021. Therefore, the need for data security is driving the growth of the healthcare technology market. Technological advancements are a key trend gaining popularity in the healthcare technology management market. Major companies operating in the market are focusing on developing innovative technologies to sustain their position in the market. For instance, in March 2022, TRIMEDX, a US-based company that provides clinical engineering, medical device cyber security, and clinical asset management solutions, launched the RUDR Score, an AI-based technology that helps in objective decision-making around clinical asset replacement. It also contains advanced benchmarking of client data. Its sophisticated cloud-based technology makes it simple to store more data in one location and make it accessible. The system also benefits by maintaining cyber security, enhancing patient safety, and maintaining the efficiency of medical equipment. In February 2022, Sodexo, a France-based technology management company, acquired hai TOPMED Information Technology Co. Ltd for an undisclosed amount. This acquisition helped Sodexo to expand its healthcare technology management service and product reach in the Chinese market. Shanghai TOPMED Information Technology Co. Ltd is a China-based technology company specializing in healthcare maintenance and management. Major players in the healthcare technology management market are GE Healthcare, Sodexo, Siemens Healthcare GmbH, TRIMEDX, Koninklijke Philips NV, Crothall Healthcare Inc, Renovo Solutions, ABM Industries Inc, Jannx Medical Systems Inc, Welldoc Inc, Agility Inc, InterMed Group, Eli Lilly and Company, Allscripts Healthcare Solutions Inc, and Athenahealth Inc. North America was the largest region in the healthcare technology management market in 2021. The regions covered in the healthcare technology management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the healthcare technology management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The global healthcare technology management market is segmented - 1) By Type Of Service: Maintenance and Repair, Capital Planning, Integrated Software Platform, Labor Management, Supply Chain (Procurement), Cyber Security, Quality and Regulatory Compliance 2) By Facility Type: Acute Care Facility, Post Acute Care Facility, Non Acute Care Facility